Get the Stockscreener App
0.5917
4.12%
-0.0254
AEON Biopharma Inc. stock is traded at $0.5917, with a volume of 139.58K.
It is down -4.12% in the last 24 hours and down -44.18% over the past month.
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.
See More
Previous Close:
$0.6171
Open:
$0.608
24h Volume:
139.58K
Relative Volume:
1.02
Market Cap:
$24.50M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-27.84%
1M Performance:
-44.18%
6M Performance:
-61.33%
1Y Performance:
-86.64%
1-Day Range:
$0.58
$0.644
1-Week Range:
$0.58
$0.88
52-Week Range:
$0.58
$17.17
AEON Biopharma Inc. Stock (AEON) Company Profile
Name
AEON Biopharma Inc.
Sector
Industry
Phone
(949) 354-6499
Address
5 Park Plaza, Suite 1750, Irvine
Compare AEON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| AEON | 0.5923 | 24.50M | 0 | 0 | 0 | 0.00 |
| VRTX | 467.17 | 119.83B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 760.51 | 83.28B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 565.09 | 33.74B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 230.39 | 30.38B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.56 | 24.08B | 3.30B | -501.07M | 1.03B | 11.54 |
AEON Biopharma Inc. Stock (AEON) Latest News
Blue Owl Capital Holdings LP Acquires New Stake in AEON Biopharm - GuruFocus.com
AEON Biopharma : Reports Third Quarter 2024 Financial Results and Provides Corporate Update Form 8 K - Marketscreener.com
AEON Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update - The Manila Times
AEON Biopharma Advances BOTOX Biosimilar Development, Secures FDA Meeting Milestone | AEON Stock News - StockTitan
AEON Biopharma Inc. (AEON) Stock: Exploring a Year of Highs, Lows, and Trading Volume - The InvestChronicle
AEON Biopharma Releases New Investor Presentation - TipRanks
AEON Biopharma stock earns buy rating, holds price target on FDA meeting - Investing.com
AEON Biopharma maps FDA path for Botox biosimilar - Investing.com
AEON receives positive outcome in FDA biosimilar advisory meeting - MSN
AEON Biopharma Announces Positive Outcome from FDA Biosimilar Advisory Meeting - The Manila Times
AEON Biopharma (AMEX:AEON) Stock Quotes, Forecast and News Summary - Benzinga
AEON Biopharma, Inc. (AEON) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - MSN
Trading Day Triumph: AEON Biopharma Inc. (AEON) Ends at 0.83, a -12.12 Surge/Plunge - The Dwinnex
AEON Biopharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024 - ForexTV.com
HC Wainwright Analysts Raise Earnings Estimates for AEON Biopharma, Inc. (NASDAQ:AEON) - Defense World
Vanguard Group Inc. Increases Position in AEON Biopharma, Inc. (NASDAQ:AEON) - Defense World
AEON Biopharma (NASDAQ:AEON) Given New $5.00 Price Target at HC Wainwright - Defense World
HC Wainwright Weighs in on AEON Biopharma, Inc.’s FY2028 Earnings (NASDAQ:AEON) - Defense World
H.C. Wainwright sees potential in AEON Biopharma stock despite funding uncertainties - Investing.com Canada
Midday Stock Roundup: Veritone Soars on NCAA Deal - Orange County Business Journal
AEON Stock Earnings: AEON Biopharma Beats EPS for Q2 2024 - InvestorPlace
AEON Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com
AEON Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update - wallstreet:online
AEON Biopharma : Corporate Presentation - Marketscreener.com
AEON Biopharma Inc. (AEON) Stock: From Low to High in 52 Weeks - The InvestChronicle
AEON Biopharma Releases New Corporate Presentation - TipRanks
Ratio Analysis: Unpacking AEON Biopharma Inc. (AEON)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
AEON Biopharma (NASDAQ:AEON) Shares Down 11.8% - MarketBeat
Was there any good news for AEON Biopharma Inc. (AEON) stock in the last session? - US Post News
AEON Biopharma (NASDAQ:AEON) Trading Down 11.8% - Defense World
The Psychology of AEON Biopharma Inc. Inc. (AEON) Price Performance: Understanding Market Sentiment - The InvestChronicle
Insider’s View: Deciphering AEON Biopharma Inc. (AEON)’s Financial Health Through Ratios - The Dwinnex
Midday Stock Roundup: loanDepot Rises on Investor Hopes for Fed - Orange County Business Journal
Views of Wall Street’s Leading Experts on AEON Biopharma Inc. - SETE News
How to interpret AEON Biopharma Inc. (AEON)’s stock chart patterns - US Post News
AEON Biopharma Inc. (AEON) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
AEON Biopharma Inc.’s Market Journey: Closing Weak at 2.64, Down -7.69 - The Dwinnex
3 Penny Stocks to Watch Now, 7/18/24 - TipRanks
A significant driver of top-line growth: AEON Biopharma Inc. (AEON) - SETE News
Wall Street-Heavily Traded - WDRB
Why Match Group Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
AEON’s Financial Health: Exploring AEON Biopharma Inc.’s Debt-to-Equity Ratio of 1.79 - The InvestChronicle
AEON Biopharma Inc. Stock (AEON) Financials Data
There is no financial data for AEON Biopharma Inc. (AEON). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
3.39%
0.01%
Cap:
|
Volume (24h):